Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
E

ETRA

Nasdaq

Electra Therapeutics, Inc.

Latest disclosureSeptember 23, 2026
Insider score Why 62?
62/ 100
Qualifying buys · 30d
$40M

4 purchases · 0 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 28

Limited filing history
All28Buying4Selling0Other24
Filters

Last 30 daysInsiders bought $40M · 2 buyers, led by Carl L. Gordon (Director) with $20M. No qualifying insider sales.

28 trades · September 21, 2026 – September 21, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.

Showing the first 6 of 28 trades on this page.

Conversion disclosed

Carl L. Gordon

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 21, 2026Filed September 23, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 21, 2026Filed September 23, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 21, 2026Filed September 23, 2026SEC filing
Purchase disclosed

Carl L. Gordon

Director

Common Stock

Reported value
$5M
Reported price
$15.00 / share
Traded September 21, 2026Filed September 23, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 21, 2026Filed September 23, 2026SEC filing
Purchase disclosed

Carl L. Gordon

Director

Common Stock

Reported value
$15M
Reported price
$15.00 / share
Traded September 21, 2026Filed September 23, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Series A Convertible Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 21, 2026Filed September 23, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Series B Convertible Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 21, 2026Filed September 23, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Series C Convertible Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 21, 2026Filed September 23, 2026SEC filing
Conversion disclosed

Carl L. Gordon

Director

Series C Convertible Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 21, 2026Filed September 23, 2026SEC filing
Conversion disclosed

Orbimed Advisors +2 more

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 21, 2026Filed September 23, 2026SEC filing
Conversion disclosed

Orbimed Advisors +2 more

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 21, 2026Filed September 23, 2026SEC filing
Conversion disclosed

Orbimed Advisors +2 more

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 21, 2026Filed September 23, 2026SEC filing
Purchase disclosed

Orbimed Advisors +2 more

Director

Common Stock

Reported value
$5M
Reported price
$15.00 / share
Traded September 21, 2026Filed September 23, 2026SEC filing
Conversion disclosed

Orbimed Advisors +2 more

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 21, 2026Filed September 23, 2026SEC filing
Purchase disclosed

Orbimed Advisors +2 more

Director

Common Stock

Reported value
$15M
Reported price
$15.00 / share
Traded September 21, 2026Filed September 23, 2026SEC filing
Conversion disclosed

Orbimed Advisors +2 more

Director

Series A Convertible Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 21, 2026Filed September 23, 2026SEC filing
Conversion disclosed

Orbimed Advisors +2 more

Director

Series B Convertible Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 21, 2026Filed September 23, 2026SEC filing
Conversion disclosed

Orbimed Advisors +2 more

Director

Series C Convertible Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 21, 2026Filed September 23, 2026SEC filing
Conversion disclosed

Orbimed Advisors +2 more

Director

Series C Convertible Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 21, 2026Filed September 23, 2026SEC filing
Conversion disclosed

Gary S. Koe

Chief Technical Officer

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 21, 2026Filed September 21, 2026SEC filing
Conversion disclosed

Gary S. Koe

Chief Technical Officer

Series A Convertible Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 21, 2026Filed September 21, 2026SEC filing
Conversion disclosed

Nancy Stagliano

Director

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 21, 2026Filed September 21, 2026SEC filing
Conversion disclosed

Nancy Stagliano

Director

Series A Convertible Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 21, 2026Filed September 21, 2026SEC filing
Conversion disclosed

Graham Parry

Chief Scientific Officer

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 21, 2026Filed September 21, 2026SEC filing
Conversion disclosed

Graham Parry

Chief Scientific Officer

Series A Convertible Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 21, 2026Filed September 21, 2026SEC filing
Conversion disclosed

Quehuong (Kathy) Dong

President & CEO

Common Stock

Value context
Unavailable
Reported price
Price not reported
Traded September 21, 2026Filed September 21, 2026SEC filing
Conversion disclosed

Quehuong (Kathy) Dong

President & CEO

Series A Convertible Preferred Stock

Derivative security · not the ordinary share price.

Value context
Not a separate purchase
Exercise / conversion price
Exercise / conversion price not reported
Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Traded September 21, 2026Filed September 21, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
DirectorCommon StockConversion2,002,310Price not reportedUnavailableSep 21Filed Sep 23 · 2d laterSEC filing
DirectorCommon StockConversion1,087,934Price not reportedUnavailableSep 21Filed Sep 23 · 2d laterSEC filing
DirectorCommon StockConversion1,703,314Price not reportedUnavailableSep 21Filed Sep 23 · 2d laterSEC filing
DirectorCommon StockPurchase333,333$15.00 / share$5MSep 21Filed Sep 23 · 2d laterSEC filing
DirectorCommon StockConversion758,279Price not reportedUnavailableSep 21Filed Sep 23 · 2d laterSEC filing
DirectorCommon StockPurchase1,000,000$15.00 / share$15MSep 21Filed Sep 23 · 2d laterSEC filing
DirectorSeries A Convertible Preferred StockConversionDerivative units2,002,310Exercise / conversion price not reportedNot a separate purchaseSep 21Filed Sep 23 · 2d laterSEC filing
DirectorSeries B Convertible Preferred StockConversionDerivative units1,087,934Exercise / conversion price not reportedNot a separate purchaseSep 21Filed Sep 23 · 2d laterSEC filing
DirectorSeries C Convertible Preferred StockConversionDerivative units1,703,314Exercise / conversion price not reportedNot a separate purchaseSep 21Filed Sep 23 · 2d laterSEC filing
DirectorSeries C Convertible Preferred StockConversionDerivative units758,279Exercise / conversion price not reportedNot a separate purchaseSep 21Filed Sep 23 · 2d laterSEC filing
+2DirectorCommon StockConversion2,002,310Price not reportedUnavailableSep 21Filed Sep 23 · 2d laterSEC filing
+2DirectorCommon StockConversion1,087,934Price not reportedUnavailableSep 21Filed Sep 23 · 2d laterSEC filing
+2DirectorCommon StockConversion1,703,314Price not reportedUnavailableSep 21Filed Sep 23 · 2d laterSEC filing
+2DirectorCommon StockPurchase333,333$15.00 / share$5MSep 21Filed Sep 23 · 2d laterSEC filing
+2DirectorCommon StockConversion758,279Price not reportedUnavailableSep 21Filed Sep 23 · 2d laterSEC filing
+2DirectorCommon StockPurchase1,000,000$15.00 / share$15MSep 21Filed Sep 23 · 2d laterSEC filing
+2DirectorSeries A Convertible Preferred StockConversionDerivative units2,002,310Exercise / conversion price not reportedNot a separate purchaseSep 21Filed Sep 23 · 2d laterSEC filing
+2DirectorSeries B Convertible Preferred StockConversionDerivative units1,087,934Exercise / conversion price not reportedNot a separate purchaseSep 21Filed Sep 23 · 2d laterSEC filing
+2DirectorSeries C Convertible Preferred StockConversionDerivative units1,703,314Exercise / conversion price not reportedNot a separate purchaseSep 21Filed Sep 23 · 2d laterSEC filing
+2DirectorSeries C Convertible Preferred StockConversionDerivative units758,279Exercise / conversion price not reportedNot a separate purchaseSep 21Filed Sep 23 · 2d laterSEC filing
Chief Technical OfficerCommon StockConversion63,656Price not reportedUnavailableSep 21Filed Sep 21 · 0d laterSEC filing
Chief Technical OfficerSeries A Convertible Preferred StockConversionDerivative units63,656Exercise / conversion price not reportedNot a separate purchaseSep 21Filed Sep 21 · 0d laterSEC filing
DirectorCommon StockConversion255,635Price not reportedUnavailableSep 21Filed Sep 21 · 0d laterSEC filing
DirectorSeries A Convertible Preferred StockConversionDerivative units255,635Exercise / conversion price not reportedNot a separate purchaseSep 21Filed Sep 21 · 0d laterSEC filing
Chief Scientific OfficerCommon StockConversion85,504Price not reportedUnavailableSep 21Filed Sep 21 · 0d laterSEC filing
Chief Scientific OfficerSeries A Convertible Preferred StockConversionDerivative units85,504Exercise / conversion price not reportedNot a separate purchaseSep 21Filed Sep 21 · 0d laterSEC filing
President & CEOCommon StockConversion455,484Price not reportedUnavailableSep 21Filed Sep 21 · 0d laterSEC filing
President & CEOSeries A Convertible Preferred StockConversionDerivative units455,484Exercise / conversion price not reportedNot a separate purchaseSep 21Filed Sep 21 · 0d laterSEC filing

Congress transactions 0

All Congress filings
No disclosed congressional trades for ETRA in the imported filings.

This reflects the filings imported so far, not a complete trading history.

Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

Qualifying common-equity purchase value

$35,999,991 of common-equity purchase value after transaction-age decay across 180 days.

+25 pts

Distinct buying groups

2 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.

+13 pts

Insider buying cluster

2 buying groups inside 30 transaction-date days, public by the snapshot cutoff.

+15 pts

Material reported holdings increase

At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.

+9 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0002088082
Latest public acceptance
Sep 23, 2026, 09:35 PM UTC
Score calculated
Oct 8, 2026, 12:11 AM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.